MMMagda Maruza

Magda Maruza

*This is an algorithmically generated author record based on publicly available information.

Magda Maruza has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Survival of people living with HIV who defaulted from tuberculosis treatment in a cohort, Recife, Brazil

    by R Cunha, M Maruza, Ur Montarroyos, I Coimbra, D de B Miranda-Filho, M de F Albuquerque, Hr Lacerda, Raa Ximenes

    Tuberculosis is a serious public health problem worldwide. It is the leading cause of death amongst people living with HIV, and default from tuberculosis (TB) treatment in people living with HIV increases the probability of death. The aim of this study was to estimate the survival probability of people living with HIV who default treatment for TB compared to those who complete the treatment. This was a longitudinal cohort study of people living with HIV, from June 2007 to December 2013 with two components: a retrospective (for those who started tuberculosis treatment before 2013 for whom failure (death) or censoring occurred before 2013), and prospective (those who started tuberculosis treatment at any time between 2007 and June 2013 and for whom death or censoring occurred after the beginning of 2013), at two referral hospitals for people living with HIV (Correia Picanço Hospital - HCP and at Hospital Universitário Oswaldo Cruz – HUOC), in Recife/PE. A total of 317 patients who initiated TB treatment were studied. Default from TB treatment was defined as any patient who failed to attend their pre-booked return appointment at the health center for more than 30 consecutive days, in accordance with Brazilian Ministry of Health recommendations. From a cohort of 2372 people living with HIV we analyzed 317 patients who had initiated TB treatment. The incidence of death was 5.6 deaths per 100 persons per year (CI 95% 4.5 to 7.08). Independent factors associated with death: default from TB treatment 3.65 HR (95% CI 2.28 to 5.83); CD4 < 200 cells/mm3 2.39 HR (95% CI 1.44 to 3.96); extrapulmonary tuberculosis 1.56 HR (95% CI 0.93 to 2.63); smoking 2.28 HR (95% CI 1.33 to 3.89); alcohol light 0.13 HR (95% CI 0.03 to 0.56). The probability of death in people living with HIV who default TB treatment is approximately four times greater when compared to those who do not default from treatment.


  • Open Access

    Empirical treatment for TB in HIV: lessons from a cohort study of people living with HIV treated in Recife, Brazil

    by Maria Fátima de Pessoa Militão Albuquerque, Isabella Coimbra, Joanna D’arc Batista, Magda Maruza, Ricardo A A Ximenes, Heloísa R Lacerda, Demócrito B Miranda-Filho, Marcela L Santos, Laura C Rodrigues

    Tuberculosis (TB) is the leading cause of death related to HIV worldwide. This study analyzes the survival of People Living with HIV (PLHIV) reporting cough without bacteriological confirmation of TB and identify factors associated with death.


  • Open Access

    Associated factors for treatment delay in pulmonary tuberculosis in HIV-infected individuals: a nested case-control study

    by Isabella Coimbra, Magda Maruza, Maria de Fátima Pessoa Militão-Albuquerque, Líbia Vilela Moura, George Tadeu Nunes Diniz, Demócrito de Barros Miranda-Filho, Heloísa Ramos Lacerda, Laura Cunha Rodrigues, Ricardo Arraes de Alencar Ximenes

    The delay in initiating treatment for tuberculosis (TB) in HIV-infected individuals may lead to the development of a more severe form of the disease, with higher rates of morbidity, mortality and transmissibility. The aim of the present study was to estimate the time interval between the onset of symptoms and initiating treatment for TB in HIV-infected individuals, and to identify the factors associated to this delay.


  • Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.

    by M. Maruza, M. F. P. M. Albuquerque, M. C. Braga, M. T. S. Barbosa, R. Byington, I. Coimbra, L. V. Moura, J. D. L. Batista, G. T. N. Diniz, D. B. Miranda-Filho, et al.

    To estimate the probability of survival and to evaluate risk factors for death in a cohort of persons living with human immunodeficiency virus (PLHIV) who had started tuberculosis (TB) treatment.


  • Open Access

    Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil: a prospective cohort study

    by Magda Maruza, Maria Fp Militão Albuquerque, Isabella Coimbra, Líbia V Moura, Ulisses R Montarroyos, Demócrito B Miranda Filho, Heloísa R Lacerda, Laura C Rodrigues, Ricardo Aa Ximenes

    Concomitant treatment of Human Immunodeficiency Virus (HIV) infection and tuberculosis (TB) presents a series of challenges for treatment compliance for both providers and patients. We carried out this study to identify risk factors for default from TB treatment in people living with HIV.


  • Open Access

    Desfecho do tratamento e confirmação laboratorial do diagnóstico de tuberculose em pacientes com HIV/AIDS no Recife, Pernambuco, Brasil

    by Magda Maruza, Ricardo Arraes de Alencar Ximenes, Heloísa Ramos Lacerda

    OBJETIVO: Comparar a freqüência de desfecho desfavorável (óbito, abandono e falência de tratamento) entre pacientes com co-infecção tuberculose (TB)/HIV submetidos a tratamento para TB com confirmação etiológica do diagnóstico e pacientes co-infectados com TB/HIV e tratados sem confirmação diagnóstica. MÉTODOS: Coorte retrospectivo de pacientes co-infectados com TB/HIV que iniciaram tratamento para TB entre julho de 2002 e junho de 2004, em um serviço de referência para HIV/AIDS no Recife (PE) Brasil. A exposição principal, confirmação laboratorial da TB, foi ajustada pelas variáveis de três blocos: variáveis sócio-demográficas; variáveis relacionadas ao HIV/AIDS; e variáveis relacionadas à TB. Para avaliar a significância estatística dos resultados, utilizaram-se o intervalo de confiança de 95% das odds ratios e o valor de p (teste de qui-quadrado e razão de verossimilhança). RESULTADOS: Foram estudados 262 pacientes. Não se observou associação entre confirmação laboratorial do diagnóstico de TB e desfecho desfavorável, mesmo após o ajuste pelos fatores de confusão. Permaneceram no modelo final da regressão logística múltipla: coexistência de outras doenças oportunistas; contagem de linfócitos CD4 abaixo de 50 células/mm³; carga viral entre 10.000 e 100.000 cópias/mL; dispnéia; forma disseminada de TB; e mudança do tratamento da TB por reação adversa ou intolerância. CONCLUSÕES: Os resultados sugerem que o tratamento para TB sem confirmação etiológica, em pacientes co-infectados, baseado na decisão de profissionais experientes em serviços de referência, não aumentou o risco de desfecho desfavorável do tratamento para TB. Além disso, identificaram-se grupos com maior risco de desfecho desfavorável, os quais devem ser cuidadosamente monitorados.